Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The present article focuses on psychoneuroendocrine effects of cannabinoids in developing animals, with special emphasis on the perinatal, periweanling and periadolescent periods. We describe and discuss published data dealing with acute and long-term effects of exposure to cannabinoid agonists in such critical periods. Human studies have demonstrated that the consumption of marijuana by women during pregnancy affects the neurobehavioural development of their children. Investigations using animal models provide useful information for a better understanding of the long-lasting deleterious consequences of cannabis exposure during pregnancy and lactation. The increasing use of cannabis among adolescents and its associated public health problems have led to a parallel increase in basic research on appropriate animal models. Chronic administration of cannabinoid agonists during the periadolescent period causes persistent behavioural alterations in adult animals. Some of these alterations may be related to a possible increased risk of psychosis and other neuropsychiatric disorders in early onset cannabis users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433 · cited 4×
“development characterized by special neurobehavioural plasticity and specific neurobiological and behavioural features (Laviola et al., 1999; Spear, 2000; Adriani and Laviola, 2004).”
BackgroundInfluentialSexual Differentiation of the Central Nervous System
MacLusky, N. J., & Naftolin, F. (1981) · Science · doi:10.1126/science.6163211 · Cited by 1,469 · cited 2×
“…sexual dimorphisms found in diverse developmental studies (see below), these gender differences in both cannabinoid receptor density and activation, might be dependent on the effects of perinatal androgens during the critical period of brain sexual differentiation (McLusky and Naftolin, 1981).”
BackgroundModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · cited 3×
“…applications of drugs acting at cannabinoid receptors (appetite stimulants, anti-emetic, analgesics in neuropathic pain, cancer, etc.) (Chaperon and Thiébot, 1999; Fuentes et al., 1999; Williamson and Evans, 2000; Cota et al., 2003; Kathuria et al., 2003; Hall et al., 2005; Viveros et al., 2005).”
BackgroundLaviola, G., Macrı̀, S., Morley-Fletcher, S., & Adriani, W. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00006-x · Cited by 621
Fried, P. A., Watkinson, B., & Gray, R. (2003) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(03)00029-1 · Cited by 458
Laviola, G., Adriani, W., Terranova, M. L., & Gerra, G. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00032-9 · Cited by 345
Synergistic interactions between cannabinoid and opioid analgesics
Cichewicz, D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.038 · Cited by 305 · cited 1×
“Numerous studies performed in adult animals have revealed the existence of functional interactions between the opioid and the endocannabinoid systems in the modulation of different behavioural responses (Maldonado and Valverde, 2003; Cichewicz, 2004; Corchero et al., 2004; Fattore et al., 2004).”
BackgroundCannabinoids in Clinical Practice
Williamson, E. M., & Evans, F. J. (2000) · Drugs · doi:10.2165/00003495-200060060-00005 · Cited by 283
Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model
Adriani, W., & Laviola, G. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00005 · Cited by 267 · cited 3×
“Moreover, it is during adolescence that some major neuropsychiatric disorders may become evident, including schizophrenia (Adriani and Laviola, 2004).”
BackgroundFried, P. A., Watkinson, B., & Gray, R. (1992) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(92)90036-a · Cited by 255 · cited 3×
“, 1998), and is associated with deficits in sustained attention (Fried et al., 1992; Fried and Watkinson, 2001).”
Background
Cited by
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Rubino, T., Vigano', D., Realini, N., Guidali, C., Braida, D., Capurro, V., Castiglioni, C., Cherubino, F., Romualdi, P., Candeletti, S., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301664 · Cited by 345
Craft, R. M., Marusich, J. A., & Wiley, J. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.009 · Cited by 299
Rubino, T., Realini, N., Braida, D., Guidi, S., Capurro, V., Viganò, D., Guidali, C., Pinter, M., Sala, M., Bartesaghi, R., et al. (2009) · Hippocampus · doi:10.1002/hipo.20554 · Cited by 282
“…the different stages of brain development, as cannabinoids influence the release and action of different neurotransmitters and promote neurogenesis (Viveros et al., 2005), exposure to cannabinoids during this developmental phase may conceivably lead to subtle but lasting changes in the brain and…”
BackgroundCannabis use in young people: The risk for schizophrenia
Casadio, P., Fernandes, C., Murray, R. M., & Di Forti, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.007 · Cited by 206
“The majority of work into the effects of cannabis during development has focused on prenatal and perinatal exposure periods (Viveros et al., 2005).”
Background
Metadata
- Authors
- Viveros, M. P., Llorente, R., Moreno, E., & Marco, E. M.
- Venue
- Behavioural Pharmacology
- Published
- 2005-09
- Volume
- 16
- Issue
- 5-6
- Pages
- 353-362
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W2008470260
- Cited by
- 101
- References
- 13
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. https://app.cochat.ai/papers/10.1097/00008877-200509000-00007
- The paper
- Viveros, M. P., Llorente, R., Moreno, E., & Marco, E. M. (2005). Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behavioural Pharmacology. https://doi.org/10.1097/00008877-200509000-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.